Scientist doing test in a lab, wearing a net on hair and safety glasses and a mask

In the fast-evolving world of biotechnology and pharmaceuticals, efficient supply chain management for clinical trials is critical.

The specialised transport and logistics of time - and temperature-sensitive materials like Cell and Gene Therapies (CGT), require advanced technology, continuous education and industry collaboration.

Michael Sweeney, QuickSTAT’s Global Head of Strategy for CGT & DTP, shares his insights on the importance of the Global Clinical Supplies Group (GCSG).

What you'll learn

  • How QuickSTAT operates 24/7/265 to ensure lifesaving therapies reach patients on time and under strict temperature controls.​

  • Overcoming CGT challenges with specific strategies to handle the complex logistics demands of the rapidly growing market.​

  • The close collaboration between clinical trial sponsors and logistics providers to eliminate handling errors and speed up the process.

Loading iFrame

Press play to get started.

Why it matters

  • In Direct-to-patient (DTP) trials, any supply chain delay directly impacts a patient’s treatment and well-being.​

  • CGTs are irreplaceable. Maintaining cold chain integrity prevents the catastrophic loss of invaluable medical protocols.​

  • Engaging with organisations like the GCSG ensures the industry stays ahead of regulatory updates and technological innovations.